PRDM1 and breast carcinoma: Previous studies indicated that AP-1 is involved in BCR-mediated and TGF-β-induced Blimp-1 gene expression in B lymphocytes (Calame, 2008) and breast cancer cells (Romagnoli et al., 2012), respectively.